These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 16029218

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Peroxisome proliferator-activated receptorsgamma (PPARgamma) differently modulate the interleukin-6 expression in the peri-infarct cortical tissue in the acute and delayed phases of cerebral ischaemia.
    Patzer A, Zhao Y, Stöck I, Gohlke P, Herdegen T, Culman J.
    Eur J Neurosci; 2008 Nov; 28(9):1786-94. PubMed ID: 18973594
    [Abstract] [Full Text] [Related]

  • 3. Activation of cerebral peroxisome proliferator-activated receptors γ (PPARγ) reduces neuronal damage in the substantia nigra after transient focal cerebral ischaemia in the rat.
    Zuhayra M, Zhao Y, von Forstner C, Henze E, Gohlke P, Culman J, Lützen U.
    Neuropathol Appl Neurobiol; 2011 Dec; 37(7):738-52. PubMed ID: 21366664
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
    Luo Y, Yin W, Signore AP, Zhang F, Hong Z, Wang S, Graham SH, Chen J.
    J Neurochem; 2006 Apr; 97(2):435-48. PubMed ID: 16539667
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Neuroprotective effect of pioglitazone on acute phase changes induced by partial global cerebral ischemia in mice.
    Medhi B, Aggarwal R, Chakrabarti A.
    Indian J Exp Biol; 2010 Aug; 48(8):793-9. PubMed ID: 21341537
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Acute neuroprotection by pioglitazone after mild brain ischemia without effect on long-term outcome.
    Ji S, Kronenberg G, Balkaya M, Färber K, Gertz K, Kettenmann H, Endres M.
    Exp Neurol; 2009 Apr; 216(2):321-8. PubMed ID: 19146854
    [Abstract] [Full Text] [Related]

  • 16. A novel mechanism of FK506-mediated neuroprotection: downregulation of cytokine expression in glial cells.
    Zawadzka M, Kaminska B.
    Glia; 2005 Jan 01; 49(1):36-51. PubMed ID: 15390105
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. FK506 protects against various immune responses and secondary degeneration following cerebral ischemia.
    Brecht S, Waetzig V, Hidding U, Hanisch UK, Walther M, Herdegen T, Neiss WF.
    Anat Rec (Hoboken); 2009 Dec 01; 292(12):1993-2001. PubMed ID: 19728359
    [Abstract] [Full Text] [Related]

  • 19. Src family kinase-inhibitor PP2 reduces focal ischemic brain injury.
    Lennmyr F, Ericsson A, Gerwins P, Akterin S, Ahlström H, Terént A.
    Acta Neurol Scand; 2004 Sep 01; 110(3):175-9. PubMed ID: 15285775
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.